Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study

This publication has 47 references indexed in Scilit:

• ApoAV Reduces Plasma Triglycerides by Inhibiting Very Low Density Lipoprotein-Triglyceride (VLDL-TG) Production and Stimulating Lipoprotein Lipase-mediated VLDL-TG Hydrolysis
  Journal of Biological Chemistry, 2004
• Analysis of Apolipoprotein A5, C3, and Plasma Triglyceride Concentrations in Genetically Engineered Mice
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
• Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5
  Biochemical and Biophysical Research Communications, 2004
• Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α Activators
  Journal of Biological Chemistry, 2003
• Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.
  Human Molecular Genetics, 2002
• Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism
  Current Opinion in Lipidology, 2002
• Apolipoprotein A-V
  Journal of Biological Chemistry, 2001
• An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing
  Science, 2001
• Triglycerides: risk factor or fellow traveler?
  Current Opinion in Cardiology, 2001
• Triglycerides and atherogenic lipoproteins: rationale for lipid management
  The American Journal of Medicine, 1998